A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS. (Q36402492)

14 August 2017

A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS. (English)

1 reference

14 August 2017

8

Anthony S Fauci

1 reference

14 August 2017

Netanya S Utay

5

0 references

Irini Sereti

object named as

Irini Sereti

9

0 references

Virginia Sheikh

4

object named as

Virginia Sheikh

1 reference

14 August 2017

6

Gregg Roby

1 reference

14 August 2017

Denise C Hsu

1

1 reference

14 August 2017

Kimberly F Faldetta

2

1 reference

14 August 2017

Luxin Pei

3

1 reference

14 August 2017

Adam Rupert

7

1 reference

14 August 2017

language of work or name

English

0 references

publication date

22 September 2015

1 reference

Clinical Infectious Diseases

14 August 2017

1 reference

14 August 2017

62

1 reference

14 August 2017

2

1 reference

14 August 2017

258-261

1 reference

Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

Tumor necrosis factor alpha in mycobacterial infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

Tuberculosis complicated by immune reconstitution inflammatory syndrome in a patient on anti-TNFα therapy for Crohn's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

A life-threatening central nervous system-tuberculosis inflammatory reaction nonresponsive to corticosteroids and successfully controlled by infliximab in a young patient with a variant of juvenile idiopathic arthritis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

Adalimumab treatment of life-threatening tuberculosis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690485

Systemic steroid treatment of paradoxical upgrading reaction in patients with lymph node tuberculosis

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26394669

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximab

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26394669

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26394669

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/CID/CIV841

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

26394669

1 reference